Gene · 55540
Papers2,488
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,488
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural basis of diverse substrate recruitment by the HIV-1 Vpr-hijacked CRL4(VprBP) E3 ligase. | PLoS Pathog | 2026 | 42821551 | PubTator, text mining | PubMed |
| Therapeutic response to exclusive enteral nutrition correlates with suppressed IL-17 signaling activity and diminished IL-1β secretion in pediatric Crohn's disease. | Front Nutr | 2026 | 42807469 | PubTator, text mining | PubMed |
| Integrated bulk-single-cell transcriptomics identifies IL17RB as a candidate prognostic marker in colon cancer. | In Silico Pharmacol | 2026 | 42798395 | PubTator, text mining | PubMed |
| Gallic acid enhances radiosensitivity in pancreatic ductal adenocarcinoma models in association with CRL4-DCAF1-related CDK1 destabilization and ROS-associated DNA damage amplification. | Phytomedicine | 2026 | 42790317 | PubTator, text mining | PubMed |
| Breast Cancer Index and Recommendations for Extended Endocrine Therapy. | JAMA Netw Open | 2026 | 42783373 | PubTator, text mining | PubMed |
| TRI-611, a selective, brain-penetrant molecular glue degrader of ALK. | Nature | 2026 | 42717093 | PubTator, text mining | PubMed |
| Topology Resetting During Transcription-Coupled Nucleotide Excision Repair. | Int J Mol Sci | 2026 | 42653251 | PubTator, text mining | PubMed |
| Construction and validation of a nomogram for the diagnosis of postmenopausal osteoporosis. | Mol Med Rep | 2026 | 42596822 | PubTator, text mining | PubMed |
| Integrated Transcriptomic Analysis of NOTCH1- and MYB-Associated Immune Features in SACC. | Int J Mol Sci | 2026 | 42511840 | PubTator, text mining | PubMed |
| RepID orchestrates CDH1 and CTNNB1 homeostasis to regulate metastatic potential in small cell lung cancer. | Biochem Biophys Res Commun | 2026 | 42485799 | PubTator, text mining | PubMed |
| CRISPR/Cas9 screen identifies DCAF4 as a novel protector of hepatocellular carcinoma against brachytherapy via stress granule-dependent NRF2 activation. | Cell Death Dis | 2026 | 42449099 | PubTator, text mining | PubMed |
| Synthesis and Development of Novel Small-Molecule MEIS2 Inhibitors That Induce Cell Death in Breast Cancer Cells by Targeting the Homeobox Domain. | Pharmaceuticals (Basel) | 2026 | 42356499 | PubTator, text mining | PubMed |
| Fibrocytes with different phenotypes are recruited in chronic obstructive pulmonary disease. | Sci Rep | 2026 | 42297864 | PubTator, text mining | PubMed |
| Targeting IL-17 family cytokines and receptors in hepatocellular carcinoma: From biology to combination immunotherapy. | Biochim Biophys Acta Rev Cancer | 2026 | 42214769 | PubTator, text mining | PubMed |
| CRL4AMBRA1-mediated progesterone receptor degradation drives progestin resistance and represents a therapeutic vulnerability in endometrial cancer. | Int J Biol Sci | 2026 | 42157930 | PubTator, text mining | PubMed |
| A new 4-atom linker enables PROTAC development and imaging. | RSC Chem Biol | 2026 | 42094781 | PubTator, text mining | PubMed |
| Circulating inflammatory ILC2s as a biomarker of gastric cancer progression. | bioRxiv | 2026 | 42094548 | PubTator, text mining | PubMed |
| Enabling Access to sp3-Enriched Targeted Protein Degraders via Redox-Neutral Radical Cross-Coupling. | Angew Chem Int Ed Engl | 2026 | 42084017 | PubTator, text mining | PubMed |
| Genetic comparisons of interleukin-17 reveal a framework for complex signaling evolution. | bioRxiv | 2026 | 42039560 | PubTator, text mining | PubMed |
| An interactome-based framework for DDB1- and CUL4-associated factor prioritization in targeted protein degradation. | Mol Cell | 2026 | 41932313 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55540/papers